BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22872210)

  • 1. Boston type I keratoprosthesis: Review.
    Magalhães FP; Sousa LB; Oliveira LA
    Arq Bras Oftalmol; 2012; 75(3):218-22. PubMed ID: 22872210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Boston keratoprosthesis.
    Saeed HN; Shanbhag S; Chodosh J
    Curr Opin Ophthalmol; 2017 Jul; 28(4):390-396. PubMed ID: 28383302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Boston keratoprosthesis].
    Wang L; Huang Y; James C; Dohlman CH
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term Interim Results of Clinical Outcomes and Complications After Implantation of Boston Keratoprosthesis in Japanese Patients.
    Ono T; Mori Y; Nejima R; Iwasaki T; Fukuda M; Minami K; Miyata K
    Cornea; 2020 Nov; 39 Suppl 1():S28-S33. PubMed ID: 32925428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Boston keratoprosthesis type 1].
    Harissi-Dagher M; Slim E
    J Fr Ophtalmol; 2019 Mar; 42(3):295-302. PubMed ID: 30857801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
    Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
    J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
    Zerbe BL; Belin MW; Ciolino JB;
    Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in management of the Boston Keratoprosthesis Type 1.
    Koo EH; Hannush SB
    Curr Opin Ophthalmol; 2021 Jul; 32(4):385-388. PubMed ID: 33973907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.
    Bonneau S; Tong CM; Yang Y; Harissi-Dagher M
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2781-2790. PubMed ID: 35384455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A multicenter clinical trial of collar-button type keratoprosthesis implantation for the treatment of corneal blindness in high-risk transplantation].
    Zhang T; Wang LL; Gu JJ; Xu JJ; Chen W; Huang YF; Hong JX; Wang T; Li SX; Gao H; Wang JT; Shi WY
    Zhonghua Yan Ke Za Zhi; 2023 Apr; 59(4):262-271. PubMed ID: 37012589
    [No Abstract]   [Full Text] [Related]  

  • 15. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
    Bakshi SK; Graney J; Paschalis EI; Agarwal S; Basu S; Iyer G; Liu C; Srinivasan B; Chodosh J
    Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.
    Lin M; Bhatt A; Haider A; Kim G; Farid M; Schmutz M; Mosaed S
    PLoS One; 2017; 12(8):e0182190. PubMed ID: 28777800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
    Shanbhag SS; Senthil S; Mohamed A; Basu S
    Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston type 1 keratoprosthesis for failed keratoplasty.
    Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.